These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7078356)

  • 1. 3H-dopamine binding to rat striatal D-2 and D-3 sites: enhancement by magnesium and inhibition by guanine nucleotides and sodium.
    Hamblin MW; Creese I
    Life Sci; 1982 May; 30(18):1587-95. PubMed ID: 7078356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of assay conditions in determining agonist potency at D2 dopamine receptors in striatal homogenates.
    de Vries DJ; Beart PM
    Brain Res; 1986 Jul; 387(1):29-35. PubMed ID: 3742232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.
    Hamblin MW; Leff SE; Creese I
    Biochem Pharmacol; 1984 Mar; 33(6):877-87. PubMed ID: 6712712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnesium ions reveal nanomolar potency of dopamine at [3H]spiperone labelled D-2 receptors in rat corpus striatum.
    De Vries DJ; Beart PM
    Eur J Pharmacol; 1985 Mar; 109(3):417-9. PubMed ID: 3157589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of GTP on 3H-domperidone binding and its displacement by dopamine in rat striatal homogenates.
    Lazareno S
    J Recept Res; 1983; 3(1-2):163-75. PubMed ID: 6854546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of agonist binding to A2A adenosine receptors: effects of guanine nucleotides (GDP[S] and GTP[S]) and Mg2+ ion.
    Mazzoni MR; Martini C; Lucacchini A
    Biochim Biophys Acta; 1993 Dec; 1220(1):76-84. PubMed ID: 8268248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guanine nucleotides do not inhibit tritiated dopamine agonist binding to bovine striatal membranes.
    Near JA; Mahler HR
    Neurochem Res; 1982 Jul; 7(7):831-7. PubMed ID: 7121724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
    Makman MH; Dvorkin B; Horowitz SG; Thal LJ
    Brain Res; 1980 Aug; 194(2):403-18. PubMed ID: 6770965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation by estradiol and progesterone of the GTP effect on striatal D-2 dopamine receptors.
    Lévesque D; Di Paolo T
    Biochem Pharmacol; 1993 Feb; 45(3):723-33. PubMed ID: 8095140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S; Nahorski SR
    Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor.
    Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR
    Endocrinology; 1988 Aug; 123(2):922-31. PubMed ID: 2969327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ontogenetic development of the striatal [3H]spiperone binding: regulation by sodium and guanine nucleotide in rats.
    Nomura Y; Oki K; Segawa T
    J Neurochem; 1982 Apr; 38(4):902-8. PubMed ID: 6174692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
    Leff SE; Creese I
    Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of GTP and sodium on rat striatal dopamine receptors labeled with lisuride.
    Uzumaki H; Govoni S; Memo M; Carruba MO; Trabucchi M; Spano PF
    Brain Res; 1982 Sep; 248(1):185-7. PubMed ID: 7127137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of agonist and antagonist binding to striatal D-1 dopamine receptors: studies using the selective D-1 antagonist [3H]SK&F R-83566.
    Flaim KE; Gessner GW; Crooke ST; Heys JR; Weinstock J
    Life Sci; 1986 Jun; 38(23):2087-96. PubMed ID: 2872567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of kainic acid and 6-hydroxydopamine lesions, metal ions and GTP on in vitro binding of the D-2 dopamine agonist, [3H]N-0437, to striatal membranes.
    Van der Weide J; De Vries JB; Tepper PG; Horn AS
    Eur J Pharmacol; 1987 Nov; 143(1):101-7. PubMed ID: 3121365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates.
    Gundlach AL; Krstich M; Beart PM
    Brain Res; 1983 Nov; 278(1-2):155-63. PubMed ID: 6227373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic binding sites in rat striatal slices and the action of guanyl nucleotides.
    Martres MP; Sokoloff P; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):116-23. PubMed ID: 6717609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The characterization of [3H]sulpiride binding sites in rat striatal membranes.
    Imafuku J
    Brain Res; 1987 Feb; 402(2):331-8. PubMed ID: 3828800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of rat striatal D-2 dopamine receptors solubilized with the zwitterionic detergent CHAPS.
    Kilpatrick GJ; Jenner P; Marsden CD
    J Pharm Pharmacol; 1985 May; 37(5):320-8. PubMed ID: 2862240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.